Patent Assignment
Reel/Frame 029004/0251
Change of Name
Recorded: 2012-09-18
Pages: 4
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92130
Covered Property
(1)
Methods for Treating Diabetes with Extended Release Formulations of Glp-1 Receptor Agonists
PCT:
PCT/US2012/043615 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 18, 2012
From: ZIERHUT, MATTHEW L.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 028981/0618 →
Assignment of Assignor's Interest
Sep 18, 2012
From: CIRINCIONE, BRENDA B.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 028981/0746 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →